The Valley Desk

NCT06075537 · Interventional trial

An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

Overall registry status Enrolling by invitation

Phase 2 · Phase 3

Conditions Mucopolysaccharidosis II

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov